304 related articles for article (PubMed ID: 34073720)
1. Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma.
Napoli F; Listì A; Zambelli V; Witel G; Bironzo P; Papotti M; Volante M; Scagliotti G; Righi L
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073720
[TBL] [Abstract][Full Text] [Related]
2. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
[TBL] [Abstract][Full Text] [Related]
3. Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms.
Cersosimo F; Barbarino M; Lonardi S; Vermi W; Giordano A; Bellan C; Giurisato E
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830817
[TBL] [Abstract][Full Text] [Related]
4. The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review.
Désage AL; Karpathiou G; Peoc'h M; Froudarakis ME
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206956
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma.
Patil NS; Righi L; Koeppen H; Zou W; Izzo S; Grosso F; Libener R; Loiacono M; Monica V; Buttigliero C; Novello S; Hegde PS; Papotti M; Kowanetz M; Scagliotti GV
J Thorac Oncol; 2018 Jan; 13(1):124-133. PubMed ID: 29079455
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications.
Tolani B; Acevedo LA; Hoang NT; He B
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342862
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma.
Marcq E; Siozopoulou V; De Waele J; van Audenaerde J; Zwaenepoel K; Santermans E; Hens N; Pauwels P; van Meerbeeck JP; Smits EL
Oncoimmunology; 2017; 6(1):e1261241. PubMed ID: 28197385
[TBL] [Abstract][Full Text] [Related]
8. Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.
Naka T; Hatanaka Y; Marukawa K; Okada H; Hatanaka KC; Sakakibara-Konishi J; Oizumi S; Hida Y; Kaga K; Mitsuhashi T; Matsuno Y
Diagn Pathol; 2016 Apr; 11():38. PubMed ID: 27091358
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma.
Horio D; Minami T; Kitai H; Ishigaki H; Higashiguchi Y; Kondo N; Hirota S; Kitajima K; Nakajima Y; Koda Y; Fujimoto E; Negi Y; Niki M; Kanemura S; Shibata E; Mikami K; Takahashi R; Yokoi T; Kuribayashi K; Kijima T
Cancer Sci; 2020 Aug; 111(8):2895-2906. PubMed ID: 32530527
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in malignant pleural mesothelioma: a review of literature data.
Menis J; Pasello G; Remon J
Transl Lung Cancer Res; 2021 Jun; 10(6):2988-3000. PubMed ID: 34295692
[TBL] [Abstract][Full Text] [Related]
11. Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma.
Hiltbrunner S; Mannarino L; Kirschner MB; Opitz I; Rigutto A; Laure A; Lia M; Nozza P; Maconi A; Marchini S; D'Incalci M; Curioni-Fontecedro A; Grosso F
Front Oncol; 2021; 11():660039. PubMed ID: 34249695
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Alteration of Human T Cells Exposed Continuously to Asbestos.
Kumagai-Takei N; Yamamoto S; Lee S; Maeda M; Masuzzaki H; Sada N; Yu M; Yoshitome K; Nishimura Y; Otsuki T
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419731
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma.
Minnema-Luiting J; Vroman H; Aerts J; Cornelissen R
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29601534
[TBL] [Abstract][Full Text] [Related]
14. Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.
Salaroglio IC; Kopecka J; Napoli F; Pradotto M; Maletta F; Costardi L; Gagliasso M; Milosevic V; Ananthanarayanan P; Bironzo P; Tabbò F; Cartia CF; Passone E; Comunanza V; Ardissone F; Ruffini E; Bussolino F; Righi L; Novello S; Di Maio M; Papotti M; Scagliotti GV; Riganti C
J Thorac Oncol; 2019 Aug; 14(8):1458-1471. PubMed ID: 31078776
[TBL] [Abstract][Full Text] [Related]
15. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H
BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176
[TBL] [Abstract][Full Text] [Related]
16. Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas.
Combaz-Lair C; Galateau-Sallé F; McLeer-Florin A; Le Stang N; David-Boudet L; Duruisseaux M; Ferretti GR; Brambilla E; Lebecque S; Lantuejoul S
Hum Pathol; 2016 Jun; 52():9-18. PubMed ID: 26980049
[TBL] [Abstract][Full Text] [Related]
17. Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma.
de Perrot M; Wu L; Cabanero M; Perentes JY; McKee TD; Donahoe L; Bradbury P; Kohno M; Chan ML; Murakami J; Keshavjee S; Tsao MS; Cho BCJ
J Thorac Cardiovasc Surg; 2020 May; 159(5):2082-2091.e1. PubMed ID: 31866087
[TBL] [Abstract][Full Text] [Related]
18. Genomics and Functional Genomics of Malignant Pleural Mesothelioma.
Cakiroglu E; Senturk S
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882916
[TBL] [Abstract][Full Text] [Related]
19. Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma.
Fiorilla I; Martinotti S; Todesco AM; Bonsignore G; Cavaletto M; Patrone M; Ranzato E; Audrito V
Cells; 2023 Aug; 12(16):. PubMed ID: 37626858
[TBL] [Abstract][Full Text] [Related]
20. Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.
Lievense LA; Bezemer K; Cornelissen R; Kaijen-Lambers ME; Hegmans JP; Aerts JG
Lung Cancer; 2017 May; 107():36-40. PubMed ID: 27168021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
